Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bintrafusp Alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma. TRUST Study

NCT04874311 is registered in ClinicalTrials.gov with Institut Bergonié as lead sponsor.

NCT NCT04874311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04874311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bintrafusp Alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma. TRUST Study
Lead sponsor
Institut Bergonié
Phase
Phase 2
Overall status
Active, not recruiting
Start date
March 1, 2022
Completion date
July 31, 2027
Enrollment
80 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

advanced soft-tissue sarcoma, metastatic soft-tissue sarcoma